(SAN DIEGO)Genetic test maker Sequenom Inc. said Thursday it priced a public offering of 5.5 million common shares at $15.50 each, a slight discount to the stock's $15.94 closing price We...READ MORE
(SAN DIEGO)Sequenom Inc., which makes genetic testing products, said Monday it will launch a public offering of 5.5 million of its common shares, or about 12 percent of the company's outs...READ MORE
(NEW YORK)Shares of Sequenom Inc. climbed to a six-year high Friday, capping a lengthy surge after the company said its prenatal Down syndrome test was effective.READ MORE
(NEW YORK)Shares of genetic test maker Sequenom Inc. fell Tuesday, a day after the company was served with a patent infringement lawsuit, though analysts and the company's chief financia...READ MORE
(NEW YORK)Genetic and molecular diagnostic company Sequenom Inc. said Monday it is being sued over its iPLEX DNA analysis system by Beckman Coulter Inc. and Orchid Cellmark Inc.READ MORE
Sequenom Inc. provider of genetic analysis and services said on Wednesday that its device to detect Down syndrome in a prenatal stage, showed no margin of error when tested in 200 ...READ MORE
(NEW YORK)Shares of Sequenom Inc., which makes genetic analysis products, surged Wednesday after the company said its prenatal test which screens maternal blood for Down syndrome was effecti...READ MORE